Forschungsprojekte
Ergebnisse pro Seite:
10
2009 - 2012
Changes of cerebral spinal fluid APPSα levels under oral therapy with acitretin 30 mg daily in patients with mild to moderate Alzheimer’s disease: a multicenter prospective randomised placebo-controlled parallel-group study (Alzheimer’s Disease Acitretin Medication-ADAM)- PD Dr. Andreas Fellgiebel,
- Tobias Wittig
2009 - 2013
Effekte von Koffein, Methylphenidat, und Modafinil auf die kognitiven Leistungen bei Schachspielern. Eine randomisierte, placebokontrollierte, doppelblinde Phase-I Studie an gesunden Probanden mit intraindividuellem cross-over Design. (“Cognitive Hyper-performance – Effects of Stimulating Substances in chess-players (CHESS)”)- Prof. Dr. Klaus Lieb,
- Dr. Dr. A. Franke,
- Tobias Wittig
2009 - 2010
Evaluation of MedJet Digestive Tract Lumen Cleaning Device Safety and Efficacy in Patients Undergoing Colonoscopy.- Univ.-Prof. Dr. Ralf Kiesslich
2009 - 2010
Effect of 16 weeks use of the DuoSlim intragastric balloon on weight loss in obese individuals.- Univ.-Prof. Dr. Ralf Kiesslich
2009 - 2012
A randomized, placebo-controlled phase II trial investigating SUNITINIB versus placebo in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus treated with chemotherapy FOLFIRI (SUN-CASE)- PD Dr. Markus Moehler,
- Univ.-Prof. Dr. Peter R. Galle,
- Dr. Lukas Schollenberger
2009 - 2013
Preparation of Neuroplant® 300mg N in film-coated tablets (St. John´s wort, SJW) in the treatment of mild to moderate Major Depressive Disorder (MDD) in adolescents from 12 to 17 years (inclusive): a parallel group, randomized, double-blind, placebo (PBO)-controlled, multicentre clinical trial to evaluate the efficacy, safety, somatic and behavioral Adverse Events (AEs) and pharmacokinetics of SJW in mild to moderate MDD in adolescents. (DEMIJO)- Dr. Michael Kölch,
- Prof. Dr. Jörg M. Fegert,
- Dr. Oliver Deuster
2009 - 2014
Randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder – the EMC trial (BMBF)- Univ.-Prof. Dr. Klaus Lieb,
- PD Dr. André Tadic